References
- Hah JH, An S-Y, Sim S, et al. A population-based study on the association between rheumatoid arthritis and voice problems. Clin Rheumatol. 2016;35(7):1873–1878.
- Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108.
- Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316–1322.
- Igarashi H, Yahagi A, Saika T, et al. A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis. Immunol Lett. 2012;141(2):246–253.
- Subramani PA, Panati K, Narala VR. Curcumin Nanotechnologies and its anticancer activity. Nutr Cancer. 2017;69(3):381–393.
- Sundar DKS, Houreld NN, Abrahamse H. Therapeutic potential and recent advances of Curcumin in the treatment of aging-associated diseases. Molecules. 2018;23(4):835.
- Jankun J, Aleem AM, Malgorzewicz S, et al. Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells. Mol Cancer Ther. 2006;5(5):1371–1382.
- Ahn JK, Kim S, Hwang J, et al. Metabolomic elucidation of the effects of curcumin on fibroblast-like synoviocytes in rheumatoid arthritis. PLoS One. 2015;10(12):e0145539.
- Mande PP, Bachhav SS, Devarajan PV. Solid dispersion of curcumin as polymeric films for bioenhancement and improved therapy of rheumatoid arthritis. Pharm Res. 2016;33(8):1972–1987.
- Shang W, Zhao L-J, Dong X-L, et al. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Mol Med Rep. 2016;14(4):3620–3626.
- Amalraj A, Varma K, Jacob J, et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food. 2017;20(10):122–1030.
- Wang J, Yan S, Yang J, et al. Non-coding RNAs in rheumatoid arthritis: from bench to bedside. Front Immunol. 2019;10:3129.
- Xiong X, Shi Q, Yang X, et al. LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer. J Cell Physiol. 2019;234(9):15619–15626.
- Yan S, Shan X, Chen K, et al. LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma. Gene. 2018;679:138–149.
- Kustiarini DA, Nishigaki T, Kanno H, et al. Effects of Morinda citrifolia on rheumatoid arthritis in SKG mice. Biol Pharm Bull. 2019;42(3):496–500.
- Zhu G, Shen Q, Jiang H, et al. Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling. Pharm Biol. 2020;58(1):25–34.
- Wikandari R , Manikharda, Baldermann S, Ningrum A, Taherzadeh MJ, et al. Application of cell culture technology and genetic engineering for production of future foods and crop improvement to strengthen food security. Bioengineered. 2021;12(2):11305–11330.
- Zhou Q, Zhang L. MicroRNA-183-5p protects human derived cell line SH-SY5Y cells from mepivacaine-induced injury. Bioengineered. 2021;12(1):3177–3187.
- Wang M, Guo S, Zhang Y, et al. Remifentanil attenuates sepsis-induced intestinal injury by inducing autophagy. Bioengineered. 2021;12(2):9575–9584.
- Fu Y, Hu X, Gao Y, et al. LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis. Bioengineered. 2021;12(1):7714–7723.
- Sun M, Chen Y, Liu X, et al. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling. Bioengineered. 2021;12(1):8006–8019.
- Han D, Yu Z, Zhang H, et al. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RTqPCR, Western blotting, and immunohistochemistry. Bioengineered. 2021;12(2):10891–10904.
- Che Z, Xueqin J, Zhang Z. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p. Bioengineered. 2021;12(2):11201–11212.
- Nolan JP, Jones JC. Detection of platelet vesicles by flow cytometry. Platelets. 2017;28(3):256–262. Edinburgh.
- Huang Y, Cao S, Zhang Q, et al. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin. Arch Biochem Biophys. 2018;646:31–37.
- Susan H, Douglas K. Curcumin: a review of its’ effects on human health. Foods. 2017;6(10):92.
- Shehzad A, Qureshi M, Anwar MN, et al. Multifunctional curcumin mediate Multitherapeutic effects. J Food Sci. 2017;82(9):2006–2015.
- Guo Q, Wang Y, Xu D, et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):15.
- Calabresi E, Petrelli F, Bonifacio AF, et al. One year in review 2018: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2018;36(2):175–184.
- Park Y, Yoo S, Kim W. Role of endoplasmic reticulum stress in rheumatoid arthritis pathogenesis. J Korean Med Sci. 2014;29(1):2–11.
- Lahoti TS, Hughes JM, Kusnadi A, et al. Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Pharmacol Exp Ther. 2014;348(2):236–245.
- Varma SR, Sivaprakasam TO, Mishra A, et al. Imiquimod-induced psoriasis-like inflammation in differentiated human keratinocytes: its evaluation using curcumin. Eur J Pharmacol. 2017;813:33–41.
- Li HY, Yang M, Li Z, et al. Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-gamma activity and reducing oxidative stress. Int J Mol Med. 2017;39(5):1307–1316.
- Lao M, Xu H. Involvement of long non-coding RNAs in the pathogenesis of rheumatoid arthritis. Chin Med J (Engl). 2020;133(8):941–950.
- Liu ZQ, He WF, Wu YJ, Zhao SL, Wang L, Ouyang YY, Tang SY, et al. LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis. BMC Gastroenterol. 2020;20(1):156.